Baroda BNP Paribas Large & Mid Cap Fund
(An open ended scheme investing in both
large cap and mid cap stocks)
Baroda BNP Paribas Large & Mid Cap Fund
(An open ended scheme investing in both
large cap and mid cap stocks)
January 2025

January 2025


Investment Objective

The primary objective of the Scheme is to seek long term capital growth through investments in both large cap and mid cap stocks. However, there can be no assurance that the investment objectives of the Scheme will be realized. The Scheme does not guarantee/indicate any returns.

NAV Details (As on January 31, 2025)
Regular Plan - IDCW Option : ₹20.1854
Regular Plan - Growth Option : ₹25.5302
Direct Plan - IDCW Option : ₹22.9196
Direct Plan - Growth Option : ₹27.2694
Benchmark Index (Tier 1)

BSE 250 Large & Mid Cap TRI

Date of Allotment

September 04, 2020

Fund Manager
Fund Manager Managing fund since Experience
Mr. Sanjay Chawla 04-Sep-20 33 years
Mr. Kirtan Mehta 01-Jan-25 26 years
Load Structure

Exit Load: Upto 365 days • Redeemed or switched out upto 10% of the allotment: Nil Redeemed or switched out more than 10% of the allotment: 1% After 365 days - Nil For detailed load structure please refer Scheme Information Document of the scheme.


Lumpsum Details

Minimum Application Amount:
₹ 5,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:₹ 1,000 and in multiples of ₹ 1 thereafter.


Monthly AAUM## As on January 31, 2025 : ₹ 1,480.95 Crores
AUM## As on January 31, 2025 : ₹ 1,445.39 Crores

## excluding inter-scheme Investments, if any, by other schemes of Baroda BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS% of Net Assets
Banks 17.31%
HDFC Bank Limited 6.46%
ICICI Bank Limited 4.55%
The Federal Bank Limited 2.98%
Bank of Baroda 2.07%
AU Small Finance Bank Limited 1.25%
IT - Software 9.41%
Infosys Limited 4.68%
Tata Consultancy Services Limited 1.99%
Mphasis Limited 1.39%
Wipro Limited 1.35%
Pharmaceuticals & Biotechnology 8.91%
Concord Biotech Limited 2.46%
Ajanta Pharma Limited 1.96%
Alkem Laboratories Limited 1.93%
Divi's Laboratories Limited 1.35%
Sun Pharmaceutical Industries Limited 1.21%
Finance 8.59%
CRISIL Limited 3.48%
PNB Housing Finance Limited 2.66%
Shriram Finance Limited 2.45%
Petroleum Products 7.29%
Reliance Industries Limited 4.81%
Hindustan Petroleum Corporation Limited 2.48%
Consumer Durables 5.12%
Dixon Technologies (India) Limited 3.11%
Blue Star Limited 2.01%
Telecom - Services 3.79%
Bharti Airtel Limited 2.81%
Bharti Hexacom Limited 0.98%
Financial Technology (Fintech) 3.58%
PB Fintech Limited 3.58%
Power 3.36%
NTPC Green Energy Limited 1.69%
Power Grid Corporation of India Limited 1.67%
Electrical Equipment 3.23%
GE Vernova T&D India Limited 2.21%
ABB India Limited 1.02%
Retailing 3.19%
Zomato Limited 1.14%
FSN E-Commerce Ventures Limited 1.05%
Trent Limited 1.00%
Insurance 3.15%
Max Financial Services Limited 2.12%
ICICI Lombard General Insurance Company Limited 1.03%
Textiles & Apparels 2.48%
Page Industries Limited 2.48%
Construction 2.39%
Larsen & Toubro Limited 1.41%
Afcons Infrastructure Limited 0.98%
Capital Markets 1.99%
Computer Age Management Services Limited 1.99%
Leisure Services 1.98%
The Indian Hotels Company Limited 1.98%
Oil 1.60%
Oil India Limited 1.60%
Industrial Manufacturing 1.49%
Kaynes Technology India Limited 1.49%
Healthcare Services 1.44%
Jupiter Life Line Hospitals Limited 1.44%
Agricultural, Commercial &Construction Vehicles 1.38%
Escorts Kubota Limited 1.38%
Auto Components 1.15%
ZF Commercial Vehicle Control Systems India Limited 1.15%
Agricultural Food & other Products 1.00%
Adani Wilmar Limited 1.00%
LESS THAN 0.75% EXPOSURE 0.68%
TOTAL EQUITY HOLDING 94.51%
Total Fixed Income Holdings
TREPS, Cash & Other Net Current Assets 5.49%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 39.12% of the portfolio


For SIP Performance please click here

For Scheme Performance please click here

The scheme currently does not have a Distribution track record.


Pursuant to distribution under Income Distribution cum Capital Withdrawal (‘IDCW’) option, NAV of the IDCW option of the scheme(s) would fall to the extent of payout and statutory levy (if applicable). The amounts under IDCW options can be distributed out of investors capital (Equalization Reserve), which is part of sale price that represents realized gains. Past performance may or may not be sustained in future. The above stated distribution rate per unit is net distribution rate after deducting applicable taxes. The above distribution rates are on face value of ₹ 10 per unit.

TER - Regular Plan (%) 2.11%
TER - Direct Plan (%) 0.83%
Portfolio Turnover Ratio 0.92
Standard Deviation* 14.80%
Beta* 0.99
Sharpe Ratio* 0.63

The risk free rate of return considered for calculation of Sharpe ratio is 6.65%, as per 1 day MIBOR rate on the lastbusiness day of the month.

No of Stocks 45
Portfolio RoE (%) 17.12
EPS Growth (%) 32.81

Portfolio RoE and EPS Growth is for trailing 12 months (TTM) whereas the number of stocks is as of January 31, 2025.
This product is suitable for investors who are seeking*:

➤ Capital appreciation over long term.
➤ Investment predominantly in equity and equity related instruments of large and midcap stocks.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (BSE 250 Large & Mid Cap TRI): basis it’s constituents; As on January 31, 2025

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.